RESUMO
Monocytoid B cells are IgM(+) , IgD(-/+) , CD27(-) B cells, localized in the perisinusoidal area of the lymph node. These cells are especially prominent in infections such as those caused by toxoplasma and HIV. The ontogeny of monocytoid B cells with respect to B cell maturation is incompletely known. We analysed clonal expansion, somatic hypermutation and expression of activation-induced cytidine deaminase (AID) in monocytoid B cells. Sequence analysis of the rearranged immunoglobulin heavy chain genes amplified from microdissected monocytoid B cell zones with a high proportion of proliferating cells reveals the presence of multiple clones with low-level ongoing mutations (mean frequency: 0.46 × 10(-2) per bp). Mutation analysis of these ongoing mutations reveals strand bias, a preference of transitions over transversions as well as the occurrence of small deletions, as observed for somatically mutated immunoglobulin genes in the human germinal centre. Proliferation, ongoing mutation as well as expression of AID, combined, is evidence that monocytoid B cells acquire the mutations in the extrafollicular perisinusoidal area of the lymph node and pleads against a postgerminal centre B cell origin.
Assuntos
Subpopulações de Linfócitos B , Citidina Desaminase/biossíntese , Cadeias Pesadas de Imunoglobulinas/genética , Hipermutação Somática de Imunoglobulina , Sequência de Bases , Citidina Desaminase/genética , Análise Mutacional de DNA , Rearranjo Gênico de Cadeia Pesada de Linfócito B , Genes de Imunoglobulinas , Humanos , Linfonodos/citologia , Linfonodos/inervação , Mutação , Análise de Sequência de DNARESUMO
BACKGROUND: The addition of rituximab to combination chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP), or R-CHOP, has significantly improved the survival of patients with diffuse large-B-cell lymphoma. Whether gene-expression signatures correlate with survival after treatment of diffuse large-B-cell lymphoma is unclear. METHODS: We profiled gene expression in pretreatment biopsy specimens from 181 patients with diffuse large-B-cell lymphoma who received CHOP and 233 patients with this disease who received R-CHOP. A multivariate gene-expression-based survival-predictor model derived from a training group was tested in a validation group. RESULTS: A multivariate model created from three gene-expression signatures--termed "germinal-center B-cell," "stromal-1," and "stromal-2"--predicted survival both in patients who received CHOP and patients who received R-CHOP. The prognostically favorable stromal-1 signature reflected extracellular-matrix deposition and histiocytic infiltration. By contrast, the prognostically unfavorable stromal-2 signature reflected tumor blood-vessel density. CONCLUSIONS: Survival after treatment of diffuse large-B-cell lymphoma is influenced by differences in immune cells, fibrosis, and angiogenesis in the tumor microenvironment.
Assuntos
Perfilação da Expressão Gênica , Expressão Gênica , Linfoma Difuso de Grandes Células B/genética , Células Estromais/metabolismo , Anticorpos Monoclonais/administração & dosagem , Anticorpos Monoclonais Murinos , Protocolos de Quimioterapia Combinada Antineoplásica , Ciclofosfamida , Progressão da Doença , Doxorrubicina , Matriz Extracelular/genética , Regulação Neoplásica da Expressão Gênica , Genes MHC da Classe II , Centro Germinativo , Humanos , Fatores Imunológicos/administração & dosagem , Estimativa de Kaplan-Meier , Linfoma Difuso de Grandes Células B/tratamento farmacológico , Linfoma Difuso de Grandes Células B/mortalidade , Linfoma Difuso de Grandes Células B/patologia , Pessoa de Meia-Idade , Análise Multivariada , Neovascularização Patológica/genética , Prednisona , Prognóstico , Rituximab , Células Estromais/patologia , VincristinaRESUMO
The effects of retinoids and the peroxisome proliferator clofibric acid on peroxisomal enzyme pathways were studied in hepatocytes from both rat and rabbit. Retinoic acid and retinol increased the activity of acyl-CoA oxidase in rabbit hepatocytes around 60% and around 30% in rat hepatocytes. Exposure to clofibric acid caused an increase in acyl-CoA oxidase activity of 115% in rat hepatocytes and of 40% in rabbit hepatocytes, indicating that rabbit is less sensitive to peroxisome proliferator than rat. Simultaneous exposure to clofibric acid and retinoids did not act additatively or synergistically. Both rabbit and rat hepatocytes expressed mRNA for the peroxisome proliferator activated receptor, (PPAR), although the transcript in rabbit was slightly smaller compared to that expressed in rat hepatocytes. The effect of retinoic acid in 7800 C1 Morris rat hepatoma cells, a cell line known to have an inducible peroxisomal beta-oxidation of fatty acids, was only slight with an increase of the acyl-CoA oxidase activity of 25% compared with control cells. As for clofibric acid, which gave a 2-fold induction of the acyl-CoA oxidase activity, the effect of retinoic acid was potentiated by dexamethasone. These cells also expressed mRNA for PPAR, with the same size as that found in rat hepatocytes. The oxidation of 3 alpha,7 alpha,12 alpha-trihydroxy-5 beta-cholestanoic acid (THCA), an intermediate in bile acid formation, in rat hepatocytes increased 110% by clofibric acid and around 80% by retinoic acid. In rabbit hepatocytes, clofibric acid increased the oxidation rate 75% and retinoic acid 100%. The results presented here show similarities in the effects of retinoids and clofibric acid on the acyl-CoA oxidase activity and the oxidation rate of THCA, since they increase these two peroxisomal activities in hepatocytes in vitro. A decrease in both these enzyme activities occurs during cultivation time in untreated primary hepatocyte cultures. The present data may therefore either be explained by an increased expression or an induced stability of the enzymes involved.
Assuntos
Ácidos Cólicos/metabolismo , Ácido Clofíbrico/farmacologia , Fígado/efeitos dos fármacos , Microcorpos/efeitos dos fármacos , Ácidos Palmíticos/metabolismo , Retinoides/farmacologia , Animais , Células Cultivadas , Isomerismo , Fígado/citologia , Fígado/metabolismo , Neoplasias Hepáticas Experimentais/metabolismo , Microcorpos/metabolismo , Oxirredução , Ácido Palmítico , Coelhos , Ratos , Células Tumorais CultivadasRESUMO
It is suggested that cellular retinol-binding proteins are important for intracellular metabolism of retinol. Retinol bound to cellular retinol-binding proteins may be esterified with long chain fatty acids by the enzyme lecithin: retinol acyltransferase or may be oxidized to retinoic acid metabolites used in the mechanism of action of vitamin A. The aim of this present report was to determine whether altered levels of cellular retinol-binding protein type I influenced retinol storage and activation. Two different cell types have been examined after transfection with vectors producing sense or antisense mRNA for cellular retinol-binding protein type I. When HL60 cells were transfected with the expression vector for sense cellular retinol-binding protein type I high amounts of cellular retinol-binding protein type I mRNA and protein were produced. We observed that HL60 cells esterified less retinol than control cells without cellular retinol-binding protein type I. Cellular retinol-binding protein type I had, however, no effects on the proliferation or differentiation of HL60 cells by retinoids. Liver stellate cells transfected with the vector for sense cellular retinol-binding protein type I esterified more retinol than cells transfected with the expression vector for antisense cellular retinol-binding protein type I, while retinol esterification in control cells was intermediate. In conclusion, our data show that cellular retinol-binding protein type I influences retinol esterification both in liver stellate cells and in HL60 cells.
Assuntos
Fígado/metabolismo , Proteínas de Ligação ao Retinol/genética , Vitamina A/metabolismo , Regulação da Expressão Gênica , Técnicas de Transferência de Genes , Células HL-60 , Humanos , Fígado/citologia , Proteínas de Ligação ao Retinol/metabolismo , Proteínas Celulares de Ligação ao RetinolRESUMO
We report here the characterization of PSKH1, a novel human protein serine kinase with multiple intracellular localizations. The gene consists of three exons distributed over 35 kb of genomic DNA in region 16q22.1. The 3.4-kb cDNA predicts a protein of 424 amino acids with a calculated molecular mass of 48.1 kDa and pI of 9.6. PSKH1 is expressed in all tissues and cell lines tested as shown by Northern blots, with the highest level of abundance in testis. PSKH1 displays the highest level of similarity with rat CaM kinase I (50. 2%) over 259 amino acids in the conserved catalytic region, but lacks significant homology with proteins in the database outside the catalytic core. Polyclonal antibodies have been raised, and indirect immunofluorescence microscopy of untransfected COS-1 cells suggests that PSKH1 is localized in the Brefeldin A-sensitive Golgi compartment, at centrosomes, in the nucleus with a somewhat speckle-like presence, and more diffusely in the cytoplasm. The presence in the centrosome appears to be enhanced during osmotic stress. Immunoisolated PSKH1 does not phosphorylate any of the common kinase substrates in vitro, but autophosphorylates exclusively serines within its COOH-terminal region in an intermolecular fashion. Furthermore, autophosphorylation activity is repressed upon addition of Ca(2+)/CaM, suggesting that PSKH1 activity depends on Ca(2+) concentration in vivo.
Assuntos
Núcleo Celular/enzimologia , Centrossomo/enzimologia , Complexo de Golgi/enzimologia , Proteínas Serina-Treonina Quinases/genética , Sequência de Aminoácidos , Sequência de Bases , Proteína Quinase Tipo 1 Dependente de Cálcio-Calmodulina , Proteínas Quinases Dependentes de Cálcio-Calmodulina/genética , Compartimento Celular , Clonagem Molecular , Humanos , Masculino , Dados de Sequência Molecular , Proteínas Nucleares/genética , Fosforilação , Sinais Direcionadores de Proteínas , Transporte Proteico , Homologia de Sequência de Aminoácidos , Serina/metabolismo , Testículo/enzimologia , Distribuição TecidualRESUMO
The stellate cells of the liver are the main storage site of retinyl esters in the body. During cultivation in vitro of stellate cells isolated from rat and rabbit livers were observed that the cells rapidly loose their retinyl ester content. Freshly isolated stellate cells contain about 144 nmol of total retinol/mg of protein, while cells cultivated for 14 days contained below 0.1 nmol/mg of protein. When 3-day-old cultures were incubated for 6 h with 2 microM retinol, the cellular content increased from 5.6 to approx. 9.4 nmol of total retinyl esters/mg of protein. In contrast, little retinyl ester accumulated in 10-20-day-old cultures incubated with 2 microM retinol. At 50 microM retinol, however, the retinyl ester level did increase both with 3-day-old cultures and 10-20-day-old cultures. In parallel experiments with cultured fibroblasts esterification characteristics similar to those seen in older cultures of stellate cells were observed. When 10-day-old cultures of stellate cells were incubated with retinol alone, or in combination with palmitic acid, linoleic acid or oleic acid, the total storage of retinyl esters increased by 20-150%. In most cases, the fatty acid supplemented in the medium was found to be the dominant fatty acid esterified with retinol. Cultures of stellate cells were then exposed to a physiological concentration (1.3 microM) of radioactive retinol free in solution or bound to retinol-binding protein. With 3-day-old cultures, as well as older cultures, the cellular content of unesterified retinol was 10-20 times higher when free retinol was added compared with addition of retinol bound to retinol-binding protein. However, 2-3-fold as much radioactive retinyl esters were recovered in cells incubated with retinol-retinol-binding protein compared with retinol free in solution. These results show that retinol delivered to stellate cells from retinol-binding protein is preferentially esterified, and that the complex is handled differently to free retinol by the stellate cells.
Assuntos
Fígado/citologia , Vitamina A/metabolismo , Animais , Ésteres , Ácidos Graxos/metabolismo , Masculino , Coelhos , Ratos , Proteínas de Ligação ao Retinol/metabolismoRESUMO
Cellular retinol binding protein 1 (CRBP1) is the cytosolic carrier for retinol. It is expressed in many tissues, but the concentrations vary considerably. In Sertoli cells from immature rat testis, CRBP1 is highly expressed. The results of the present study show that regulation of CRBP1 expression at the protein level appears to be independent of regulation at the mRNA level. In Sertoli cells from prepubertal 19-day-old rats, CRBP1 mRNA is strongly induced for up to 72 h by the presence of serum factors. In contrast, treatment of the cells with cAMP analogues led to a rapid reduction in mRNA to quantities less than 5% of control values. However, the changes in CRBP1 mRNA did not lead to similar changes in the concentration of CRBP1 protein during 72 h of observation. Similarly, treatment of cells from 32- and 44-day-old rats with serum led to increased CRBP1 mRNA, whereas cAMP treatment resulted in a decrease in CRBP1 mRNA. Again, no changes were observed in the concentration of CRBP1 protein. Furthermore, co-incubation of Sertoli cells from 19-day-old rats with purified pachytene spermatocytes or round spermatids resulted in an increase in mRNA for CRBP1. However, comparable changes in CRBP1 protein concentrations were not observed. Neither cAMP nor serum changed the fraction of CRBP1 mRNA that was associated with polysomes. As a possible explanation for some of the results, pulse-chase experiments showed that the rate of CRBP1 degradation in cultured Sertoli cells is decreased by cAMP. It is proposed that these changes at the level of protein turnover contribute to the maintenance of stable concentrations of CRBP1 even when the corresponding mRNA concentrations vary markedly.
Assuntos
RNA Mensageiro/metabolismo , Proteínas de Ligação ao Retinol/genética , Células de Sertoli/metabolismo , Maturidade Sexual/fisiologia , Animais , Northern Blotting , Western Blotting , Células Cultivadas , Técnicas de Cocultura , AMP Cíclico/farmacologia , Masculino , Testes de Precipitina , Ratos , Ratos Sprague-Dawley , Proteínas de Ligação ao Retinol/metabolismo , Proteínas Celulares de Ligação ao Retinol , Espermátides/metabolismo , Espermatócitos/metabolismoRESUMO
This report describes the production and characterization of transgenic mice with high expression of human cellular retinol-binding protein type I [hCRBP(I)]. In initial experiments, overexpression of hCRBP(I) was driven by the strong promoter SR(alpha), but no transgenic offspring were produced. When we used the less efficient mouse metallothionein I promoter fused to the hCRBP(I) cDNA for microinjection, we obtained 12% transgenic offspring. Two of these transgenic mice (409/1 and 401/2) expressed mRNA and immunoreactive hCRBP(I) in several organs. Both lines had relatively high contents of hCRBP(I) in intestine, testis and epididymis. On the other hand, only 401/2 transgenic mice had high contents of hCRBP(I) in kidney. Effects on storage of vitamin A were studied by measuring the concentration of retinyl esters in different organs. The concentrations of retinyl esters in liver, lung and kidney did not significantly differ between transgenic and control mice, and the concentration of total retinol in plasma was within the normal range in transgenic mice. Furthermore, feeding mice a diet with high or low concentrations of vitamin A for 2 wks resulted in no marked differences in the concentrations of retinyl esters in liver, kidney, lung, intestine and testis in transgenic mice compared with control mice. Therefore, in spite of high expression of hCRBP(I) in several organs, the transgenic mice had normal storage of retinyl esters in all organs studied. The present in vivo study indicates that the CRBP(I) content alone does not control retinyl ester storage.
Assuntos
Camundongos Transgênicos/metabolismo , Proteínas de Ligação ao Retinol/genética , Vitamina A/metabolismo , Animais , Sequência de Bases , Northern Blotting , DNA/análise , DNA/química , DNA/genética , Feminino , Regulação da Expressão Gênica , Células HL-60 , Humanos , Mucosa Intestinal/metabolismo , Intestinos/química , Rim/química , Rim/metabolismo , Fígado/química , Fígado/metabolismo , Pulmão/química , Pulmão/metabolismo , Masculino , Metalotioneína/genética , Camundongos , Camundongos Transgênicos/genética , Dados de Sequência Molecular , Regiões Promotoras Genéticas/genética , Proteínas de Ligação ao Retinol/fisiologia , Proteínas Celulares de Ligação ao Retinol , Proteínas Plasmáticas de Ligação ao Retinol , Testículo/química , Testículo/metabolismo , Transfecção , Vitamina A/análise , Vitamina A/sangueRESUMO
The suggested function of cellular retinol-binding protein type I [CRBP(I)] is to carry retinol to esterifying or oxidizing enzymes. The retinyl esters are used in storage or transport, whereas oxidized forms such as all-trans or 9-cis retinoic acid are metabolites used in the mechanism of action of vitamin A. Thus, high expression of human CRBP(I) [hCRBP(I)] in transgenic mice might be expected to increase the production of retinoic acid in tissues, thereby inducing a phenotype resembling vitamin A toxicity. Alternatively, a vitamin A-deficient phenotype could also be envisioned as a result of an increased accumulation of vitamin A in storage cells induced by a high hCRBP(I) level. Signs of vitamin A toxicity or deficiency were therefore examined in tissues from transgenic mice with ectopic expression of hCRBP(I). Testis and intestine, the tissues with the highest expression of the transgene, showed normal gross morphology. Similarly, no abnormalities were observed in other tissues known to be sensitive to vitamin A status such as cornea and retina, and the epithelia in the cervix, trachea and skin. Furthermore, hematologic variables known to be influenced by vitamin A status such as the hemoglobin concentration, hematocrits and the number of red blood cells were within normal ranges in the transgenic mice. In conclusion, these transgenic mice have normal function of vitamin A despite high expression of hCRBP(I) in several tissues.